Investor's Business Daily on MSN48m
Why Amgen's Obesity Drug — And $5 Billion Opportunity — Led To A DowngradeAmgen stock dipped Monday after an analyst downgraded shares, saying the $5 billion opportunity for its weight-loss drug, ...
Douglas Twenefour, head of care at Diabetes UK sets the record straight on the most common misunderstandings about sugar, ...
The former immigration minister, who lost four stone in 12 months, said the drug had aided him at the start of his bid to ...
New estimates say that Medicare will spend tens of billions of dollars over nine years to cover weight-loss drugs.
Global Weight Loss Supplements Market is expanding rapidly due to people’s increasingly high focus on their weight reduction and management across the regions.
However, GLP-1-based therapies aren't going to be the only option in the weight loss medicines market forever. Some companies are pursuing other approaches that could be even more effective or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback